Gelonghui, May 14, 丨 Huluwa (605199.SH) said on the investor interactive platform that the company obtained the “Drug Registration Certificate” for terbutaline sulfate atomized inhalation solution approved and issued by the State Drug Administration on April 23, 2024, and has not yet been sold. There are currently no synthetic biological products or technology reserves.
葫芦娃(605199.SH)：没有合成生物产品或者技术储备
Gourd Wa (605199.SH): No synthetic biological products or technical reserves
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.